Position in NVS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$38,546,381
-$3,557,170 QoQ
Shares Held
245,957
-10.8% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#70
of 1,603 holders
Holding Since
Jun 2021
19 quarters on record
Voting authority
Sole 86%
Shared 0%
None 14%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Grantham, Mayo, Van Otterloo & Co. LLC holds $3,887,775,493 across 10 Drug Manufacturers - General names. NVS ranks #6 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
7,110,133 | $1,805,760,478 | |
| 2 | LLY |
ELI LILLY & Co
|
743,966 | $892,335,213 | |
| 3 | MRK |
Merck & Co., Inc.
|
6,785,008 | $871,873,528 | |
| 4 | GSK |
GSK plc
|
3,599,521 | $188,686,890 | |
| 5 | PFE |
Pfizer Inc
|
2,179,317 | $52,477,953 | |
| 6 | NVS |
Novartis AG
This page
|
245,957 | $38,546,381 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
411,483 | $23,709,650 | |
| 8 | SNY |
Sanofi
|
285,165 | $12,165,138 |
All Filings in NVS
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $38,546,381 | 245,957 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $42,103,551 | 275,637 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $41,247,257 | 299,175 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $42,451,543 | 331,032 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $42,679,621 | 352,695 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $43,716,993 | 392,151 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $56,235,546 | 577,901 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $76,490,485 | 665,019 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $83,004,839 | 779,681 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $91,494,585 | 945,876 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $154,219,053 | 1,527,375 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $186,125,009 | 1,827,263 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $68,917,089 | 682,956 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $938,400 | 10,200 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $4,082,400 | 45,000 | Shares | Sole | 2023-02-13 | |
| 2022-03-31 | $307,125 | 3,500 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $17,117,879 | 195,700 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $13,321,962 | 162,900 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $273,720 | 3,000 | Shares | Sole | 2021-08-12 | |
| No filing history on record for this holder in this stock. | ||||||